Gedatolisib FDA approval date

The FDA approved Gedatolisib (PF-05212384) on 14 Jul 2026.

FDA approval date
14 Jul 2026

Drug identity checked against registry records

Also recorded as PF-05212384; PKI-587

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-07-14DayGedatolisibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219908", "applicant_as_listed_by_fda": "CELCUITY", "brand_names": ["REVTORPYK"], "active_ingredients": ["GEDATOLISIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260714", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026